血清microRNA检测在肝细胞癌诊断中的研究进展

渠亚超; 闾军

doi:10.3969/j.issn.1001-5256.2014.03.008

血清microRNA检测在肝细胞癌诊断中的研究进展

DOI: 10.3969/j.issn.1001-5256.2014.03.008

渠亚超,
闾军

首都医科大学附属北京佑安医院肝病与肿瘤生物治疗科

基金项目:

北京市卫生系统高层次卫生技术人才培养项目资助(2011-J.L.)；首都医学发展科研基金(2009-3156)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2975
- HTML全文浏览量: 7
- PDF下载量: 673
- 被引次数: 0
出版历程
- 出版日期: 2014-03-20

Research progress in serum microRNA detection for diagnosis of hepatocellular carcinoma

Qu YaChao,
LYU Jun

Research funding:

摘要

摘要:
随着肝细胞癌(HCC)患病率和病死率的逐渐上升,寻找精确、简便易行而无创的早期诊断标志物越来越重要。小分子RNA(microRNAs,miRNAs)是一类内源性非编码的小RNA,广泛存在于动物、植物和病毒中,并且在血清和组织中均稳定表达。介绍了miRNAs作为促癌基因和抑癌基因在肿瘤发生和发展中的作用,总结了多种血清miRNAs在肝细胞癌中的异常表达情况。分析表明可以利用这些稳定表达的miRNAs作为早期诊断肿瘤的无创性标志物。
- 癌,肝细胞 /
- 微RNAs /
- 早期诊断 /
- 综述
Abstract:
With the rising incidence and mortality of HCC, accurate, simple, and non- invasive biomarkers are increasingly needed for the early diagnosis of this disease. MicroRNAs ( miRNAs) are a class of endogenous non- coding small RNAs, which have been widely found in animals, plants, and viruses and are stably expressed in both sera and tissues. The roles of miRNAs as oncogenes or tumor suppressor genes in the development and progression of HCC are described, and the aberrant expression of serum miRNAs in HCC is summarized. Analyses showed that these stably expressed miRNAs can be used as non- invasive biomarkers for early diagnosis of HCC.
- carcinoma, hepatocellular /
- microRNAs /
- early diagnosis /
- review

HTML全文

参考文献(54)

[1]PARKIN DM.Global cancer statistics in the year 2000[J].Lancet Oncol, 2001, 2 (9) :533-543.

[2]WANG J, CHAN JY, FONG CC, et al.Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines[J].Liver Int, 2009, 29 (9) :1338-1347.

[3]BOSCH FX, RIBES J, CLERIES R, et al.Epidemiology of hepatocellular carcinoma[J].Clin Liver Dis, 2005, 9 (2) :191-211.

[4]BOREL F, KONSTANTINOVA P, JANSEN PL.Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma[J].J Hepatol, 2012, 56 (6) :1371-1383.

[5] SCHWARTZ M, ROAYAIE S, KONSTADOULAKIS M.Strategies for the management of hepatocellular carcinoma[J].Nat Clin Prac Oncol, 2007, 4 (7) :424-432.

[6] POON RT, FAN ST.Hepatectomy for hepatocellular carcinoma:patient selection and postoperative outcome[J].Liver Transpl, 2004, 10 (2 Suppl 1) :s39-s45.

[7]YUEN MF, CHENG CC, LAUDER IJ, et al.Early detection of hepatocellular carcinoma increases the chance of treatment:Hong Kong experience[J].Hepatology, 2000, 31 (2) :330-335.

[8]FUKUDA S, ITAMOTO T, NAKAHARA H, et al.Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma[J].Hepatogastroenterology, 2005, 52 (64) :1163-1167.

[9]COLLIER J, SHERMAN M.Screening for hepatocellular carcinoma[J].Hepatology, 1998, 27 (1) :273-278.

[10]OKA H, TAMORI A, KUROKI T, et al.Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma[J].Hepatology, 1994, 19 (1) :61-66.

[11]ABDALLA MA, HAJ-AHMAD Y.Promising candidate urinary microrna biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C virus Egyptian patients[J].J Cancer, 2012, 3:19-31.

[12]KASAHARA A, HAYASHI N, FUSAMOTO H, et al.Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes[J].Dig Dis Sci, 1993, 38 (12) :2170-2176.

[13]BRUIX J, LLOVET JM.Prognostic prediction and treatment strategy in hepatocellular carcinoma[J].Hepatology, 2002, 35 (3) :519-524.

[14]LIU J, ZHENG M, TANG YL, et al.MicroRNAs, an active and versatile group in cancers[J].Int J Oral Sci, 2011, 3 (4) :165-175.

[15]BRACONI C, HENRY JC, KOGURE T, et al.The role of microRNAs in human liver cancers[J].Semin Oncol, 2011, 38 (6) :752-763.

[16]MELO SA, ESTELLER M.Dysregulation of microRNAs in cancer:playing with fire[J].FEBS Lett, 2011, 585 (13) :2087-2099.

[17]WANG J, SEN S.MicroRNA functional network in pancreatic cancer:from biology to biomarkers of disease[J].J Biosci, 2011, 36 (3) :481-491.

[18] FORNARI F, MILAZZO M, CHIECO P, et al.MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells[J].Cancer Res, 2010, 70 (12) :5184-5193.

[19]CHEN P, ZHAO X, MA L.Downregulation of microRNA-100correlates with tumor progression and poor prognosis in hepatocellular carcinoma[J].Mol Cell Biochem, 2013, 383 (1-2) :49-58.

[20]CHEN XM.MicroRNA signatures in liver diseases[J].World J Gastroenterol, 2009, 15 (14) :1665-1672.

[21]KIM CJ, PARK NH, CHUNG YH.Roads towards a new tailored therapy for hepatocellular carcinoma:diagnostic, therapeutic and prognostic implications of microRNAs[J].Liver Int, 2012, 32 (5) :695-697.

[22]AUGELLO C, VAIRA V, CARUSO L, et al.MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma[J].Liver Int, 2012, 32 (5) :772-782.

[23] DATTA J, KUTAY H, NASSER MW, et al.Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis[J].Cancer Res, 2008, 68 (13) :5049-5058.

[24]KIM WH, MIN KT, JEON YJ, et al.Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population[J].Gene, 2012, 504 (1) :92-97.

[25]XU J, ZHU X, WU L, et al.MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway[J].Liver Int, 2012, 32 (5) :752-760.

[26]BALA S, MARCOS M, SZABO G.Emerging role of microRNAs in liver diseases[J].World J Gastroenterol, 2009, 15 (45) :5633-5640.

[27] XIONG Y, FANG JH, YUN JP, et al.Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma[J].Hepatology, 2010, 51 (3) :836-845.

[28]HUANG XM, CHEN X, JIA ZY.Progress of artificial microRNAs in cancer gene therapy[J].Chin J Cell Biol, 2013, 35 (7) :1018-1026. (in Chinese) 黄晓明, 陈翔, 贾振宇.人工microRNAs在肿瘤基因治疗中的研究[J].中国细胞生物学学报, 2013, 35 (7) :1018-1026.

[29]ZHUANG P, LI ZY, WANG XC, et al.The functional characterization of the human liver-specific miR-122 expression in hepatocullar carcinoma[J].Chin J immunol, 2013, 29 (7) :686-688. (in Chinese) 庄鹏, 李志莹, 王湘郴, 等.肝特异性的miR-122对肝癌细胞增殖及凋亡的影响[J].中国免疫学杂志, 2013, 29 (7) :686-688.

[30] CHEN X, BA Y, MA L, et al.Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Res, 2008, 18 (10) :997-1006.

[31] MITCHELL PS, PARKIN RK, KROH EM, et al.Circulating microRNAs as stable blood-based markers for cancer detection[J].Proc Natl Acad Sci U S A, 2008, 105 (30) :10513-10518.

[32] LU J, GETZ G, MISKA EA, et al.MicroRNA expression profiles classify human cancers[J].Nature, 2005, 435 (7043) :834-838.

[33]LI J, SMYTH P, FLAVIN R, et al.Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells[J].BMC Biotechnol, 2007, 7:36.

[34]XI Y, NAKAJIMA G, GAVIN E, et al.Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples[J].RNA, 2007, 13 (10) :1668-1674.

[35] ZHOU J, YU L, GAO X, et al.Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma[J].J Clin Oncol, 2011, 29 (36) :4781-4788.

[36] ZHANG C, WANG C, CHEN X, et al.Expression profile of microRNAs in serum:a fingerprint for esophageal squamous cell carcinoma[J].Clin Chem, 2010, 56 (12) :1871-1879.

[37] WANG J, CHEN J, CHANG P, et al.MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease[J].Cancer Prev Res (Phila) , 2009, 2 (9) :807-813.

[38] WEBER JA, BAXTER DH, Zhang S, et al.The microRNA spectrum in 12 body fluids[J].Clin Chem, 2010, 56 (11) :1733-1741.

[39] CORTEZ MA, BUESO-RAMOS C, FERDIN J, et al.MicroRNAs in body fluids-the mix of hormones and biomarkers[J].Nat Rev Clin Oncol, 2011, 8 (8) :467-477.

[40]LI J, WANG Y, YU W, et al.Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance[J].Biochem Biophys Res Commun, 2011, 406 (1) :70-73.

[41]QU KZ, ZHANG K, LI H, et al.Circulating microRNAs as biomarkers for hepatocellular carcinoma[J].J Clin Gastroenterol, 2011, 45 (4) :355-360.

[42]TOMIMARU Y, EGUCHI H, NAGANO H, et al.Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma[J].J Hepatol, 2012, 56 (1) :167-175.

[43] XU J, WU C, CHE X, et al.Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis[J].Mol Carcinog, 2011, 50 (2) :136-142.

[44] QI P, CHENG SQ, WANG H, et al.Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection[J].PLoS One, 2011, 6 (12) :e28486.

[45] LI LM, HU ZB, ZHOU ZX, et al.Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma[J].Cancer Res, 2010, 70 (23) :9798-9807.

[46] LIU AM, YAO TJ, WANG W, et al.Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma:a retrospective cohort study[J].BMJ Open, 2012, 2 (2) :e000825.

[47]MENG F, HENSON R, WEHBE-JANEK H, et al.MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J].Gastroenterology, 2007, 133 (2) :647-658.

[48]LIU C, YU J, YU S, et al.MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma[J].J Hepatol, 2010, 53 (1) :98-107.

[49]KIM S, LEE UJ, KIM MN, et al.MicroRNA miR-199a*regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2) [J].J Biol Chem, 2008, 283 (26) :18158-18166.

[50]LI L, GUO Z, WANG J, et al.Serum miR-18a:a potential marker for hepatitis B virus-related hepatocellular carcinoma screening[J].Dig Dis Sci, 2012, 57 (11) :2910-2916.

[51] GUI J, TIAN Y, WEN X, et al.Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies[J].Clin Sci (Lond) , 2011, 120 (5) :183-193.

[52] ROSENFELD N, AHARONOV R, MEIRI E, et al.MicroRNAs accurately identify cancer tissue origin[J].Nat Biotechnol, 2008, 26 (4) :462-469.

[53]ZHUANG P, LI Z, WANG XC, et al.Construction of lentiviral vector carrying miR-122 and function of miR-122 in hepatocellular carcinoma cells[J].J Clin Hepatol, 2013, 29 (7) :529-531. (in Chinese) 庄鹏, 李志莹, 王湘郴, 等.miR-122慢病毒载体的构建及其在肝癌细胞中的作用[J].临床肝胆病杂志, 2013, 29 (7) :529-531.

[54] NG EK, CHONG WW, JIN H, et al.Differential expression of microRNAs in plasma of patients with colorectal cancer:a potential marker for colorectal cancer screening[J].Gut, 2009, 58 (10) :1375-1381.

施引文献

资源附件(0)

访问统计